Literature DB >> 32805023

Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.

Shijie Qin1, Xinyi Xia2,3,4, Xuejia Shi1, Xinglai Ji5, Fei Ma1, Liming Chen1.   

Abstract

SUMMARY: There are seven known coronaviruses that infect humans: four mild coronaviruses, including HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1, only cause mild respiratory diseases, and three severe coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2, can cause severe respiratory diseases even death of infected patients. Both infection and death caused by SARS-CoV-2 are still rapidly increasing worldwide. In this study, we demonstrate that viral coding proteins of SARS-CoV-2 have distinct features and are most, medium and least conserved with SARS-CoV, MERS-CoV and the rest four mild coronaviruses (HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1), respectively. Moreover, expression of host responsive genes (HRG), HRG-enriched biological processes and HRG-enriched KEGG pathways upon infection of SARS-CoV-2 shows slightly overlapping with SARS-CoV and MERS-CoV but distinctive to the four mild coronaviruses. Interestingly, enrichment of overactivation of neutrophil by HRGs is only and commonly found in infections of severe SARS-CoV-2, SARS-CoV and MERS-CoV but not in the other four mild coronaviruses, and the related gene networks show different patterns. Clinical data support that overactivation of neutrophil for severe patients can be one major factor for the similar clinical symptoms observed in SARS-CoV-2 infection compared to infections of the other two severe coronavirus (SARS-CoV and MERS-CoV). Taken together, our study provides a mechanistic insight into SARS-CoV-2 epidemic via revealing the conserved and distinct features of SARS-CoV-2, raising the critical role of dysregulation of neutrophil for SARS-CoV-2 infection.
AVAILABILITY AND IMPLEMENTATION: All data sources and analysis methods related to this manuscript are available in the methods, supplementary materials and GEO database (https://www.ncbi.nlm.nih.gov/geo/). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 32805023      PMCID: PMC7558794          DOI: 10.1093/bioinformatics/btaa725

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  4 in total

1.  Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.

Authors:  Shijie Qin; Weijun Xu; Canbiao Wang; Sizhu Jiang; Wei Dai; Yang Yang; Jiawei Shen; Ping Jin; Fei Ma; Xinyi Xia
Journal:  Brief Bioinform       Date:  2021-04-27       Impact factor: 11.622

Review 2.  Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.

Authors:  Marcos Altable; Juan Moisés de la Serna
Journal:  Virus Res       Date:  2021-02-22       Impact factor: 3.303

3.  Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.

Authors:  Fee Faysal Ahmed; Md Selim Reza; Md Shahin Sarker; Md Samiul Islam; Md Parvez Mosharaf; Sohel Hasan; Md Nurul Haque Mollah
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

4.  Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces.

Authors:  Wenrui Wu; Ding Shi; Xueling Zhu; Jiaojiao Xie; Xinyi Xu; Yanfei Chen; Jingjing Wu; Lanjuan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-12       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.